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Experimental Transmission of Chronic Wasting Disease (CWD) of
Elk (Cervus elaphus nelsoni ), White-tailed Deer (Odocoileus
virginianus), and Mule Deer (Odocoileus hemionus hemionus) to
White-tailed Deer by Intracerebral Route
A. N. HAMIR, J. A. RICHT, J. M. MILLER, R. A. KUNKLE, S. M. HALL, E. M. NICHOLSON, K. I. O’ROURKE,
J. J. GREENLEE, AND E. S. WILLIAMS
National Animal Disease Center, ARS, USDA, Ames, IA (ANH, JAR, JMM, RAK, EMN, JJG);
Pathobiology Laboratory, National Veterinary Services Laboratories, Ames, IA (SMH); Animal
Disease Research Unit, Pullman, WA (KIO); University of Wyoming, Laramie, WY (ESW1)
Abstract. To compare clinical and pathologic findings of chronic wasting disease (CWD) in a natural
host, 3 groups (n 5 5) of white-tailed deer (WTD) fawns were intracerebrally inoculated with a CWD
prion of WTD, mule deer, or elk origin. Three other uninoculated fawns served as controls.
Approximately 10 months postinoculation (MPI), 1 deer from each of the 3 inoculated groups was
necropsied and their tissues were examined for lesions of spongiform encephalopathy (SE) and for the
presence of abnormal prion protein (PrPd) by immunohistochemistry (IHC) and Western blot (WB). The
remaining deer were allowed to live until they developed clinical signs of the disease which began
approximately 18 MPI. By 26 MPI, all deer were euthanatized on humane grounds. Obvious differences
in clinical signs or the incubation periods were not observed between the 3 groups of deer given CWD. In
1 of 3 nonclinical deer euthanatized at 10 MPI, minimal microscopic lesions of SE were seen in the
central nervous system (CNS) tissues, and PrPd was observed by IHC in tissues of all 3 deer. In the
clinical deer, CNS lesions of SE and PrPd accumulations were more severe and extensive. It is concluded
that the 3 sources of CWD prion did not induce significant differences in time to clinical disease or
qualitative differences in signs or lesions in WTD. However, this observation does not imply that these
CWD agents would necessarily behave similarly in other recipient species.
Key words: Chronic wasting disease; CWD; Odocoileus virginianus; prion disease; transmissible
spongiform encephalopathy; TSE; white-tailed deer.

Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy (TSE) or prion
disease that has been identified in captive and freeranging cervids,20 namely mule deer (Odocoileus
hemionus hemionus), black-tailed deer (O. hemionus
columbianus), white-tailed deer (Odocoileus virginianus), Rocky Mountain elk (Cervus elaphus
nelsoni),14 and, recently, moose (Alces alces shirasi).1 Affected animals show accumulation of an
abnormal, disease-associated form of prion protein
(PrPd) in tissues of the central nervous system
(CNS) and lymphatic system. Presence of histopathologic spongiform lesions in CNS and detection of PrPd in CNS and lymphoid tissues are the
basis of currently available diagnostic methods for
TSEs.3
Experimentally, CWD has been transmitted by
intracerebral inoculation of infectious material
from mule deer to a variety of species, including a
1

Deceased 29 December 2004.

goat,20 cattle,4 and sheep.5 CWD from white-tailed
deer (CWDwtd) has also been transmitted experimentally by the intracerebral route to cattle and
has shown a possible higher attack rate in cattle
than CWDmd.10
Because it is not known whether CWD is caused
by one or more different prion agents (i.e., from
different species of natural hosts), the primary
objective of this study was to investigate clinical
and pathologic observations of CWD from 3
different sources in 1 host species: white-tailed deer
(WTD) that is naturally susceptible to the disease.
Materials and Methods
Animals and husbandry
Eighteen 3-month-old WTD fawns were obtained
from a CWD-free herd at the National Animal Disease
Center (NADC), Ames, Iowa. The fawns were genotyped for PRNP and assigned to 3 experimental groups
(each n 5 5) and 1 control group (n 5 3). Group No. 1
was inoculated with WTD inoculum, group No. 2 with
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Table 1. Experimental design and summary outcomes of genotype, survival period, clinical signs distribution of
microscopic brain lesions and immunohistochemical labeling, and Western blots in white-tailed deer inoculated
intracerebrally with the agent of Chronic Wasting Disease from elk, white-tailed deer, and mule deer.*
Genotype
Codon

No.

Ear
Tag
No.

1
2
3
4
5

632
648
683
628
654

QQ GG
QQ GG
NE
QQ GS
QQ GS

6
7
8
9
10

676
635
636
646
677

QQ GG
QQ GG
QQ GS
QQ GG
QQ GS

11
12
13
14
15

684
680
639
643
682

QQ GS
QQ GG
QQ GG
QQ GS
QQ GS

16
17
18

681 QH GS
679 QQ GS
645 QQ GS

95

96

CWD
Inoculation

WTD
WTD
WTD
WTD
WTD
Mean
Elk
Elk
Elk
Elk
Elk
Mean
MD
MD
MD
MD
MD
Mean
Control
Control
Control

Survival
Period
(MPI)

Clinical
Signs

Histopathology
(spongiform
encephalopathy)
BS Cerb MB Hipp RC

10.36{
2
+
17
+
+
20.17
+
NE
20.93
+
+
23.47
+
+
20.4 6 1.2 (SEM)
10.37{
2
2
17.17
+
+
17.6
+
+
17.73
+
+
24.1
+
+
19.2 6 1.4 (SEM)
9.33{
2
2
14.5
+
+
16.1
+
+
22.13
+
+
26
+
+
19.7 6 2.3 (SEM)
20.17
2
2
26.17
2
2
26.2
2
2

2
+
NE
+
+

Western
Blot BS

IHC for PrPd

BS Cerb MB Hipp RC 2 mg 20 mg

2 2
2
+ +
+
+
+
+ +
NE NE NE NE NE
+
2
2
+ +
+
+
+
+ +

+
+
+
2
+
+
+
+
+
+
NE NE NE NE NE
+
+
+
+
+
+
+
+
+
+

2
+
2
+
+

2
+
+
+
+

2
+
2
+
+

2
+
2
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

2
+
+
+
+

+
+
+
+
+

2
+
+
+
+

2
+
+
+
+

2
+
+
+
+

2
+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

2
+
+
+
+

2
+
+
+
+

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

2
2
2

* MPI 5 months postinoculation; BS 5 brainstem at obex; Cerb 5 cerebellum; MB 5 midbrain at the level of superior
colliculi; Hipp 5 hippocampus; RC 5 rostral cerebrum; IHC 5 immunohistochemistry; WTD 5 white-tailed deer; MD 5 mule
deer; NE 5 tissues not available for examination.
{ Euthanatized at 9–10 MPI (not included in the mean).

elk inoculum, and group No. 3 with mule deer
inoculum, and control group No. 4 was uninoculated
(Table 1). All CWD-inoculated deer were homozygous
at PRNP gene polymorphic amino acid sites at codon 95
(glutamine) and 116 (serine). Deer homozygous (glycine/
glycine) or heterozygous (glycine/serine) at codon 96
were approximately equally divided between treatment
groups (Table 1). Inoculated fawns were housed in a
Biosafety Level 2 isolation barn at NADC; the
husbandry of TSE-inoculated animals has been described previously.12 Personnel wore protective clothing
while in the isolation facility and showered before
leaving the facility.
Inoculum
The CWDwtd inoculum was prepared from a pool of
11 CWD-affected WTD brainstems from Wisconsin; the
CWD inoculum from elk (CWDelk) was a pool of 2
CWD-positive elk brainstems from South Dakota, and
the CWDmd inoculum was a pool of 28 CWD-affected
mule deer brains from Wyoming. In all 3 instances, the
animals from which the inocula were prepared were
positive by immunohistochemistry (IHC) for PrPd. The
affected brain tissues were ground in a mechanical
grinder, and gentamicin was added to attain a final

concentration of 100 mg/ml in the homogenized inoculum. The final concentration of the brain inoculum was
10% (wt/vol) in phosphate-buffered saline (PBS). The
pooled samples of all 3 inocula were positive for CWD
prion protein by Western blot (WB). In addition, CWD
inocula from mule deer and WTD were previously
reported effective in producing prion disease in cattle
when administered by the intracerebral route.4,10
Inoculation procedure
The deer were inoculated intracerebrally with 1 ml of
either CWDwtd, CWDelk, or CWDmd inocula as described previously for sheep.11 Briefly, the fawns were
sedated with xylazine, a midline incision was made in the
skin at the junction of the parietal and frontal bones,
and a 1-mm hole was trephined through the calvarium.
The inoculum was injected into the midbrain via a 22gauge 9-cm-long needle while withdrawing the needle
from the brain. The skin incision was closed with a
single suture.
Necropsy, tissue samples
Except for the 3 animals killed at about 10 MPI
(Nos. 632, 676, 684; Table 1), all others were euthana-
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tized when in extremis. One control animal (No. 681;
Table 1) was euthanatized earlier, and the other 2
controls were euthanatized at the termination of the
experiment (Nos. 679, 645; Table 1). Animals were
euthanatized with pentobarbital sodium overdose, and
a complete necropsy was conducted on each of the
carcasses. One deer (No. 683; Table 1) was not available
for necropsy. Representative samples of liver, kidney,
spleen, skin, striated muscles (heart, tongue, diaphragm,
masseter), thoracic aorta, thyroid gland, turbinates,
trachea, lung, tonsils, esophagus, rumen, reticulum,
omasum, abomasum, intestine (ileum), salivary gland,
adrenal gland, urinary bladder, lymph nodes (retropharyngeal, prescapular, mesenteric, popliteal), nerves
(optic, trigeminal), pituitary gland, Gasserian ganglion,
and spinal cord (cervical, thoracic, lumbar) were fixed
by immersion in 10% neutral buffered formalin. One eye
was fixed in Bouin’s solution. The brain was bisected
longitudinally; one half was fixed in formalin for not less
than 3 weeks and the other half was frozen. The
formalin-fixed brain was cut into 2–4-mm-thick coronal
sections. A minimum of 5 hemisections of brain per
animal—rostral cerebrum, hippocampus, superior colliculus, cerebellum, brainstem (at the level of obex)—
and 6 sections of spinal cord (2 each of cervical,
thoracic, and lumbar) were processed by routine
histology procedures, embedded in paraffin wax, and
sectioned at 5 mm thickness.
The sections were stained with hematoxylin and eosin
(HE). Selected sections of the brain were also stained by
periodic acid–Schiff (PAS), Gomori’s methenamine
silver (GMS), and Congo Red stains. The latter sections
were examined under polarized light to detect presence
of amyloid.
Immunohistochemistry
All paraffin-embedded tissues were also stained by an
automated IHC method for detection of PrPd as described previously.8 Monoclonal antibody (Mab), F99/
97.6.116 was used for the IHC at a final concentration of
1.0 mg/ml protein. Past experience at NADC has
indicated this antibody would recognize PrP sequences
in various species.2,4–6,9,10 CNS tissues of 1 positive
animal (No. 3661) were also labeled by IHC with Mab
6H4 (0.2 mg/ml).
Western blot analyses
Brainstem homogenates from WTD were analyzed
using the PrionicsH-Check Western Kit (Prionics,
Schlieren, Switzerland) and the OIE-recommended
Scrapie Associated Fibril (SAF)-Immunoblot method14
with minor modifications as previously described.19
PRNP genotyping: DNA isolation and polymerase chain
reaction amplification
Genomic DNA was extracted from 200 ml of a 10%
brain homogenate with the DNeasyTM tissue kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. Polymerase chain reaction was performed

in a 100-ml final reaction volume as previously
described.19
Statistical analysis
Incubation periods of the 3 treatment groups were
compared with the 2-sided Student’s t-test. Probability
values of P , .05 were considered to indicate a
statistically significant difference between groups.

Results
Three WTD euthanatized at approximately 10
MPI did not show clinical signs of CWD (Table 1).
The remainder of the CWD-inoculated deer
revealed characteristic signs of the disease, and all
were euthanatized between 18 and 26 MPI. The
clinical signs included gradual decrease in appetite
with consequent weight loss. During the latter part
of the disease (which varied from a few days to a
week) the animals had difficulty in swallowing and
were seen to regurgitate feed intermittently. There
was also excessive salivation. In the terminal phase
of the disease, the affected deer appeared to be
unaware of their surroundings; had lost fear of
humans; occasionally showed disorientation, bruxism, and intermittent circling to one side; and
eventually became recumbent. They were euthanatized when in extremis. Clinical signs in animals in
all 3 treatment groups were similar. Although the
survival times of individual deer varied from 14.5
to 26 MPI, mean survival times did not differ
significantly among groups (P $ .5; Table 1).
Except for the loss of body condition, significant
gross lesions were not seen in any of the
experimental deer. No lesions were present in the
3 control deer.
Although the 3 deer euthanatized at 10 MPI did
not have clinical signs, there were minimal microscopic lesions of spongiform encephalopathy (SE)
in the brainstem of deer No. 632 (Fig. 1; Table 1).
However, PrPd was observed by IHC in CNS
(Fig. 2) and lymphoid tissues of all 3 animals
without clinical signs (Table 1).
Lesions in the CNS were more severe and
extensive in deer with clinical signs (Table 1,
Figs. 3–6) than in deer without clinical signs
(Table 1, No. 632) euthanatized at 10 MPI. Severe
multifocal spongiform lesions consisting of vacuolation of neuropil and an occasional vacuole within
neuronal perikarya were seen in the brains and
spinal cords of all affected deer (Figs. 3–6). Mild
multifocal gliosis was seen at the affected sites, but
neuronal degeneration was not seen. Additionally,
in the rostral cerebral cortex of all deer with clinical
signs were variable numbers of randomly distributed plaques that contained eosinophilic fine
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Fig. 1. Brain, brainstem (obex), dorsal vagal nucleus; nonclinical deer No. 632 (03-1267). Moderate
spongiform encephalopathy. HE. Bar 5 60 mm.
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Fig. 4. Brain, rostral cerebral cortex; clinical deer No. 648. Higher magnification of gyrus with spongiform
encephalopathy in Fig. 5 showing several florid plaques (arrows). HE. Bar 5 60 mm.
Fig. 5. Brain, rostral cerebral cortex; clinical deer No. 648. Higher magnification of gyrus with minimal
changes in Fig. 6 showing 2 florid plaques with a few surrounding clear vacuoles (arrows). HE. Bar 5 60 mm.

fibrillar material (Figs. 4, 5). These plaques were
present both within the areas of SE (Fig. 4) as well
as some distance from these lesions (Fig. 5).
Plaques in the areas of SE were surrounded by
many clear vacuoles (florid plaques; Fig. 4),
whereas in the unaffected areas, a few small
peripheral vacuoles surrounded the plaques
(Fig. 5). Many of the plaques revealed centrally
located fibrillar GMS- and PAS-positive material
(Fig. 6). Both stains enabled easy detection of
florid plaques within a section. When examined

under polarized light, the amyloid red–stained
sections revealed faint apple-green material (amyloid) within some of the plaques.
The location of SE in the brains is summarized in
Table 1. In the brainstem, the lesions were more
severe and diffuse and although they were present
in all nuclei, they appeared to be more extensive in
the dorsal nucleus of the vagus. Lesions in the
hippocampus were moderate and multifocal. Sections of the colliculi revealed mild diffuse vacuolation in the neuropil. In the rostral cerebrum,

r
Fig. 2. Brain, brainstem (obex), dorsal vagal nucleus; nonclinical deer No. 632. Particulate labeling is scattered
in the neuropil and around neurons and blood vessels. Also, there is some PrPd labeling in the subependymal area.
Labeled for PrPd by IHC. Bar 5 60 mm.
Fig. 3. Brain, rostral cerebral cortex; clinical deer No. 648. In two adjacent gyri, the left gyrus has extensive
diffuse spongiform encephalopathy, whereas the right has minimal changes. HE. Bar 5 160 mm.
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Fig. 6. Brain, rostral cerebral cortex; clinical deer No. 648. Higher magnification showing a florid plaque with
central fibrillar PAS-positive material. PAS. Bar 5 60 mm.
Fig. 7. Brain, rostral cerebral cortex; clinical deer No. 648. There is diffuse granular PrPd labeling of cortical
gray matter. Within this area are many intensively labeled florid plaques. Labeled for PrPd by IHC. Bar 5 70 mm.
Fig. 8. Eye, retina; clinical deer No. 648. There is diffuse granular labeling of PrPd in the inner and outer
plexiform layers. The ganglion cell layer shows fine multifocal labeling. Labeled for PrPd by IHC. Bar 5 40 mm.

Vet Pathol 45:3, 2008
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lesions were confined to the cortex and consisted of
extensive multifocal to coalescing areas of SE
(Figs. 3–6). Often a severely affected gyrus would
be adjacent to a nonaffected or minimally affected
gyrus (Fig. 3). The cerebellum also had mild to
moderate multifocal areas of vacuolations in the
cerebellar folia involving predominantly the molecular and Purkinje cell layers.
A focal pulmonary abscess in 1 deer (No. 635)
suggested focal aspiration pneumonia. Other incidental findings included ectopic lymphoid follicles
in the medulla of 1 kidney in deer No. 632, focal
mineralization of the blood vessels in the brains of
3 deer (Nos. 628, 680, 681), and sarcocysts in
skeletal muscles of 5 deer. No other significant
lesions were seen in the tissues of experimental or
control deer.
Although microscopic lesions were not evident in
all brain sections, PrPd was detected by IHC in all
(Table 1). Immunolabeling by IHC was more
abundant in the CNS but roughly equivalent in
lymphoid tissues of the clinical deer compared with
the nonclinical deer that were euthanatized at
approximately 10 MPI. Differences in IHC findings
between groups (i.e., treatment groups by CWD
inocula source or codon 96 polymorphism genotype) were not noted. Negative control deer
sacrificed at 26 months postinoculation did not
have immunolabeling for PrPd.
The PrPd labeling in the CNS of deer without
clinical signs was predominantly characterized by
well-delineated and abundant accumulations in
subependymal neuropil in both brain and spinal
cord sections. The PrPd distribution in the CNS of
clinically affected deer was multifocally extensive to
diffuse and was perineuronal, subependymal, and
neuropil associated (Fig. 2). PrPd labeling was
pronounced in the midbrain but relatively sparse
in the hippocampus. Spinal cord sections revealed
PrPd accumulations predominately in the gray
matter horns. Intensely labeled plaques, with and
without peripheral neuropil vacuolation (florid
plaques), was a prominent feature in the deer with
advanced CWD (Fig. 7). Intraneuronal labeling in
the CNS was not observed.
PrPd was consistently detected by IHC in lymph
nodes, mainly in germinal centers of cortical follicles. PrPd was detected by IHC in splenic
periarteriolar sheaths in only 5 of 13 deer, with no
clear pattern of splenic labeling by IHC in relation to
stage of disease or PrP genotype. Only 3 of 13 third
eyelid specimens examined contained submucosal
lymphoid tissue, and PrPd labeling was seen in only
1 deer (No. 677). Submucosal lymphoid tissue in the
ileum (Peyer’s patches) was consistently labeled for
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PrPd, as were ganglia in the myenteric plexus. Unlike
labeling seen in the CNS, PrPd accumulations were
localized to the perikaryon as well as to perineuronal
foci in the myenteric plexus.
Gasserian ganglia were uniformly devoid of
PrPd. However, light to moderate punctuate
labeling was present in trigeminal nerve tissue
obtained from several clinically affected deer.
Retinal tissue contained abundant PrPd in all
clinically affected deer, but not in deer euthanatized
at 10 MPI. The IHC labeling localized predominately to the plexiform layers of the retina, with
lesser amounts present in the ganglion cell layer
(Fig. 8) and optic nerve of some deer.
When WB analysis with 2-mg brain equivalent
(eq) amounts was performed, all samples except
Nos. 632, 676, 684, 681, 679, and 645 showed a
pattern with the presence of all 3 isoforms of the
protease-resistant PrPd (Fig. 9). To determine
whether higher milligram equivalent amounts of
brainstem would show a different reaction pattern,
brainstems of Nos. 632, 676, and 684 were analyzed at 20-mg brain eq. At this concentration,
sample Nos. 632 and 676 were positive for PrPd
(Fig. 10). Sample No. 684 was negative at 20 mg eq
(Fig. 10), as well as at 100 mg eq (data not shown).
When representative samples from WTD inoculated either with CWDwtd, CWDmd, or CWDelk
were compared side by side, no difference in the
molecular mass of the 3 protease-resistant isoforms
(unglycosylated, monoglycosylated, diglycosylated)
of the PrPd was noted (Fig. 9). The molecular
pattern was not different when PrPd-positive deer
were compared with different PrP genotypes (e.g.,
GG96 versus GS96) (Fig. 9).
Analysis of the open reading frame of the PRNP
from codon 11 through codon 235 revealed
polymorphic sites on codons 95 and 96 (Table 1).
One animal, No. 681, was heterozygous for glutamine/histidine (Q/H; CAA/CAC) at codon 95; all
other animals were homozygous for glutamine (Q/
Q; CAA/CAA) at that position. Codon 96 can code
for either glycine (G 5 GGT) or serine (S 5 AGT).
Seven animals were homozygous (G/G) and 10
animals were heterozygous (G/S) at this position.
All animals were homozygous for alanine (A/A) at
codon 116 and for serine (S/S) at codon 138. No
unknown polymorphisms were found in the PRNP
of these animals, and the PRNP gene of all animals
encoded 5 octa/nonapeptide repeat units.19 Silent
changes were identified in some animals: GAC/
GAT at codon 20 (Nos. 628, 635, 681), CGT/CGC
at codon 51 (No. 628), AAC/AAT at codon 146
(No. 676), and ATC/ATT at codon 185 (Nos. 628,
636, 639, 645, 676, 679, 681, 682).
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Fig. 9. Western blot analysis of representative
brainstem samples from white-tailed deer inoculated
with CWDwtd (Nos. 654 and 648), CWDmd (Nos. 643
and 680), and CWDelk (Nos. 677 and 635). Deer
No. 679 represents a negative control animal. Samples
were probed with monoclonal antibody 6H4 and loaded
at 0.1–0.3 mg brain eq per lane. Positive samples show
distinct protease-resistant profiles of PrPd. Different PrP
genotypes were loaded: GS96 (Nos. 654, 677, 643) and
GG96 (Nos. 648, 635, 680). Molecular weight markers
(kDa) are indicated on the left side of the blot.
Fig. 10. Western blot analysis with monoclonal
antibody 6H4 after PrPd enrichment of brainstem.
Sample Nos. 632, 676, and 684 were loaded at 20 mg
brain eq. The positive control sample was loaded at
1 mg brain eq. Molecular weight markers (kDa) are
indicated on the left side of the blot.

Discussion
In this study, we used the intracerebral route of
inoculation to provide the most efficient means of
testing the susceptibility of WTD to the 3 agents of
CWD (from WTD, elk, and mule deer). In WTD,
polymorphism at codons 95, 96, 116, and 138 of the
PRNP gene has been reported.17 However, in this
study, although there was no uniformity at codon
96, it did not appear to have had any influence on
the outcome of disease.
Like all other TSEs, CWD is characterized by a
long incubation period, which in deer is seldom less

Vet Pathol 45:3, 2008

than 18 months.20 In our study, the mean survival
time was just over 19 MPI and was not significantly
different in the groups given 3 different CWD
isolates (Table 1). Previous studies have found
differences in attack rates in cattle4,10 after inoculation of CWDmd and CWDwtd, and similar
findings might also be true for fallow deer.7
Therefore, the indication is that more than 1 strain
of CWD could be present, and such a hypothesis
appears to be supported by other work.13,18
However, in this study, no such differences were
identified, suggesting that WTD are not appropriate challenge hosts for differentiating strains of
CWD, although the study is compromised because
the infectious dose was not determined and limiting
doses were not used.
In all cervids, clinical signs of CWD are
characterized by emaciation, changes in behavior,
and excessive salivation.20 In this study, both
excessive salivation and behavioral changes were
observed in animals that had clinical signs. Also,
weight loss was considerable, but frank emaciation
was not observed in any of the clinical deer,
possibly because the animals in the study were in a
controlled environment and were never far from
the familiar source of feed and water, which would
have helped in maintaining some body condition.
In the 3 WTD that were euthanatized at
approximately 10 MPI, there were no clinical signs
of CWD. However, on microscopic examinations,
one of the deer had microscopic lesions of SE in the
brain stem, and all 3 showed presence of PrPd in
their brains by IHC and 2 out of 3 by WB.
Although in these animals the inoculum was
administered by the intracerebral route, by 10
MPI, the lymphoid tissues of all 3 deer were
positive also for PrPd by IHC. Because of recent
evidence of presence of PrPd in blood and saliva of
CWD-infected deer,15 it is possible that during or
soon after the inoculation procedure, some of the
inoculum could have gained access to the circulatory system and hence been transported to the
lymph nodes.
In these deer, the observed neuronal lesions of
SE have been described previously.20 Microscopically, the most impressive lesion was the extensive
SE with presence of numerous plaques in the
rostral cerebral cortex. These are most frequently
seen in WTD, followed by mule deer and elk with
CWD.20
The distribution and character of PrPd labeling
by IHC in the WTD tissues was not apparently
influenced by the source of CWD inoculum or by
the genotype of the PRNP for GG96 compared
with GS96. Labeling was intense and well distrib-
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uted in lymphoid tissues in nonclinical as well as
CWD-affected deer, whereas PrPd accretion in the
CNS was apparently dependent on incubation
period. The early accumulation of PrPd in predominately subependymal foci could be a consequence
of the intracerebral inoculation method, which
targets the midbrain, including the cerebral aqueduct, as the initial point of inoculum deposition.
The increased labeling of PrPd in the CNS of
CWD-affected deer was exemplified by the uniform
presence of PrPd in retinal tissues in all but the
nonclinical deer sacrificed at 10 MPI.
The lack of intraneuronal labeling in the CNS
and total absence in the Gasserian ganglia juxtaposed to the labeling of perikaryon in myenteric
plexus neurons is an interesting and puzzling
finding. The spleen and third eyelid were poor
candidate tissues for IHC immunodiagnosis in this
study. The paucity of nictitating membrane submucosal lymphoid tissue in these deer could be a
reflection of the relatively clean, dust-free environment afforded by biocontainment housing and
consequent lack of antigenic stimulation to this
mucosal surface.
When 2-mg brain eq amounts were analyzed by
WB, all animals euthanatized with clinical signs of
CWD were positive for PrPd. The 3 animals
euthanatized without clinical signs at about 10
MPI were either questionable or negative for the
presence of PrPd. We therefore enriched PrPd using
a modified OIE-recommended WB technique.14
When 20 mg eq were loaded, 2 out of these 3
animals were WB positive (Fig. 10). The negative
animal, No. 684, was further tested at 100 mg eq
and still gave no positive signal for PrPd. This
indicates that the WB method at early time points
(MPI) when few cells are PrPd positive is not as
sensitive as the IHC method, which determined
animal No. 684 positive for PrPd (Table 1). Because one half of the brain was formalin-fixed and
analyzed by IHC and the other half was frozen and
used for WB analysis, it was also possible that the
WB sample did not contain PrPd.
No significant differences in the molecular
profile were observed in WTD inoculated with 3
different CWD inocula (CWDwtd, CWDmd,
CWDelk; Fig. 9). This was also true when different
PrP genotypes of WTD (GS96, GG96) were
compared. This indicates that CWD from different
sources inoculated into WTD results in similar
molecular phenotypes independent of the origin of
the inoculum. It was shown previously17 that
captive deer affected with CWD are less likely to
have the Q95S96A118S138 genotype and more likely
to have the Q95G96A118S138 genotype. Likewise, it
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was suggested that GS96 was linked to reduced
susceptibility to CWD and slower progression of
disease in WTD.12
With intracerebal inoculation of CWD, there
was a trend toward a longer incubation time for
deer carrying the GS96 heterozygous (mean
22.4 months) compared with GG96 homozygous
genotype (mean 16.5 months) (see Table 1). Although only a small number of animals were
enrolled in this study, the effect of codon GS96
polymorphism on incubation time was significant
(P , .01). Interestingly, the GS96 heterozygous
animal No. 684 was negative in WB even at 100 mg
brain eq, indicating a slower progression of PrPd
accumulation when compared with the other 2
animals representing the GG96 genotype sacrificed
at a similar time point postinoculation.
This study did not demonstrate obvious differences in the clinical or pathologic outcome of
infection with prion among the 3 CWD inocula
that were used to produce disease in WTD.
However, PRNP gene polymorphism at codon 96
in the recipient deer revealed differences in survival
times. Since the 2 CWD inocula (CWDwtd and
CWDmd) in cattle4,10 revealed significant differences
in attack rates, further studies are indicated to
investigate the potential role of other CWD prions
derived from different cervids, including moose.
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